Enhancing refractive lens exchange outcomes

IOL implantation in older, cataract patients often fails to enhance vision to a level that is greater than that of the average non-cataractous lens of a similar age.

It has been suggested that loss of contrast sensitivity occurs as a patient ages and this, in turn, has been linked with changes in the spherical aberration of the human crystalline lens, which increasingly becomes positive as the human eye ages and can no longer compensate the already positive corneal spherical aberration. Because many IOLs marketed today do not accommodate the enhanced spherical aberration displayed by the aging crystalline lens, IOL implantation in older, cataract patients often fails to enhance vision to a level that is greater than that of the average non-cataractous lens of a similar age. As a consequence, the patient will still experience reduced visual quality.

Since the late Sir Harold Ridley implanted the very first IOL in 1949, many have worked tirelessly to design the ultimate lens that will be free of tilt or decentration concerns, provide long-term, high quality vision and avoid complications such as posterior capsule opacification (PCO).

Though still in its infancy, the market for refractive IOLs is predicted by many to rocket over the next few years, with more and more surgeons introducing these lenses into their clinical practice. This prediction has been further supported in the US by the recent CMS (Centres for Medicare and Medicaid Services) ruling which, having acknowledged the importance of this new generation of presbyopia-correcting lenses, granted Medicare patients the right to pay a premium to receive the implants.

Traditionally, although proven to be effective in reducing spectacle dependency, multifocal IOLs have been plagued with reports of certain visual side effects, such as halos and less sharp vision. This stems from their failure to address the problem of spherical aberration.

Only recently, however, has attention been placed on creating an IOL, which deviates from the original spherical design introduced by Ridley all those years ago. In a bid to address this unmet need, a modified prolate anterior surface IOL (Tecnis, AMO) has been developed and is now setting a new standard of visual performance in cataract surgery. It is also contributing to the rising interest in RLE.

Introducing the Tecnis multifocal IOL

CE-marked since 2004, the developers have added a diffractive multifocal optic to the posterior surface of the lens, resulting in the creation of the modified prolate multifocal Tecnis IOL. Instead of aggravating the problem of spherical aberration, as seen with spherical IOLs, the multifocal Tecnis lens actually neutralizes the spherical aberration of the average older cornea.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
EDOF lens tech is evolving to help more patients with intermediate vision
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Advancing IOL technology for treatment of presbyopia
Dexamethasone insert reduces time spent planning cataract surgery, counselling patients
Addressing gaps in vision care with a wearable diagnostic platform
Presbyopia-correcting drops provide hope for frustrated patients
Related Content
© 2023 MJH Life Sciences

All rights reserved.